Jon Napitupulu

Moffitt Cancer Center and AstraZeneca have forged a strategic partnership to advance the development of cell therapies, particularly CAR-T...

The U.S. Food and Drug Administration (FDA) has authorized Ocrevus Zunovo, a new subcutaneous injection, to treat relapsing and...

The globally connected home medical monitoring devices market is expanding rapidly. In 2023, the number of such devices reached...

The global drug discovery informatics market is projected to reach $4.8 billion by 2030, expanding at a compound annual...

Contraline, a biotechnology company, has secured an exclusive licensing agreement with the Population Council for NES/T Gel, an investigational...

SpectraWAVE, a medical imaging innovator, has secured $50 million in Series B funding led by Johnson & Johnson Innovation...

Molecular Targeting Technologies (MTTI) and Brookline Capital Markets are collaborating at the 2nd Targeted Radionuclide Pharmaceuticals (TRPs) Supply Chain...

Genethon, a leading gene therapy research facility, has significantly progressed in developing a new generation of adeno-associated virus (AAV)...

GI Partners has acquired a majority stake in eClinical Solutions, a leading provider of digital clinical software and services,...

Results from the Phase 3 PURPOSE 2 clinical trial have confirmed the effectiveness of Lenacapavir, an injectable HIV-1 capsid...